Bio View Stock Total Debt
| BIOV Stock | ILS 29.80 0.00 0.00% |
Bio View fundamentals help investors to digest information that contributes to Bio View's financial success or failures. It also enables traders to predict the movement of Bio Stock. The fundamental analysis module provides a way to measure Bio View's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bio View stock.
Bio |
Bio View Company Total Debt Analysis
Bio View's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Bio View Total Debt | 2.57 M |
Most of Bio View's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bio View is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Based on the latest financial disclosure, Bio View has a Total Debt of 2.57 M. This is 99.91% lower than that of the Health Care Equipment & Supplies sector and 99.85% lower than that of the Health Care industry. The total debt for all Israel stocks is 99.95% higher than that of the company.
Bio Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bio View's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bio View could also be used in its relative valuation, which is a method of valuing Bio View by comparing valuation metrics of similar companies.Bio View is currently under evaluation in total debt category among related companies.
Bio Fundamentals
| Return On Equity | 0.0399 | |||
| Return On Asset | 0.0091 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 35.4 M | |||
| Shares Outstanding | 13.75 M | |||
| Shares Owned By Insiders | 51.58 % | |||
| Price To Book | 1.72 X | |||
| Price To Sales | 1.71 X | |||
| Revenue | 30.51 M | |||
| Gross Profit | 17.59 M | |||
| EBITDA | 4.72 M | |||
| Net Income | 2.18 M | |||
| Cash And Equivalents | 17.67 M | |||
| Cash Per Share | 1.24 X | |||
| Total Debt | 2.57 M | |||
| Debt To Equity | 11.80 % | |||
| Current Ratio | 2.14 X | |||
| Book Value Per Share | 2.00 X | |||
| Cash Flow From Operations | 3.25 M | |||
| Earnings Per Share | 0.09 X | |||
| Number Of Employees | 35 | |||
| Beta | 0.53 | |||
| Market Capitalization | 53.86 M | |||
| Total Asset | 40.02 M | |||
| Retained Earnings | (29 M) | |||
| Working Capital | 18 M | |||
| Current Asset | 26 M | |||
| Current Liabilities | 8 M | |||
| Z Score | 12.0 | |||
| Net Asset | 40.02 M |
About Bio View Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bio View's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio View using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio View based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Bio View
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio View position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio View will appreciate offsetting losses from the drop in the long position's value.Moving together with Bio Stock
| 0.61 | GIVO-L | GIVOT OLAM OIL | PairCorr |
Moving against Bio Stock
| 0.57 | SAFE | Safe T Group | PairCorr |
| 0.57 | BMDX | Biomedix Incubator | PairCorr |
| 0.46 | BSP | Black Sea Property | PairCorr |
| 0.46 | ICB | Israel China Biotech | PairCorr |
The ability to find closely correlated positions to Bio View could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio View when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio View - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio View to buy it.
The correlation of Bio View is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio View moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio View moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bio View can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio View. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for Bio Stock analysis
When running Bio View's price analysis, check to measure Bio View's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio View is operating at the current time. Most of Bio View's value examination focuses on studying past and present price action to predict the probability of Bio View's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio View's price. Additionally, you may evaluate how the addition of Bio View to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |